FitLife Brands EPS - Earnings per Share 2012-2025 | FTLF
FitLife Brands eps - earnings per share from 2012 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| FitLife Brands Annual EPS | |
|---|---|
| 2024 | $0.91 |
| 2023 | $0.54 |
| 2022 | $0.45 |
| 2021 | $0.57 |
| 2020 | $0.97 |
| 2019 | $1.17 |
| 2018 | $0.05 |
| 2017 | $-1.16 |
| 2016 | $0.05 |
| 2015 | $-0.16 |
| 2014 | $0.25 |
| 2013 | $0.18 |
| 2012 | $0.04 |
| 2011 | $0.00 |
| FitLife Brands Quarterly EPS | |
|---|---|
| 2025-09-30 | $0.09 |
| 2025-06-30 | $0.18 |
| 2025-03-31 | $0.20 |
| 2024-12-31 | $0.22 |
| 2024-09-30 | $0.21 |
| 2024-06-30 | $0.27 |
| 2024-03-31 | $0.21 |
| 2023-12-31 | $0.15 |
| 2023-09-30 | $0.18 |
| 2023-06-30 | $0.20 |
| 2023-03-31 | $0.02 |
| 2022-12-31 | $0.05 |
| 2022-09-30 | $0.12 |
| 2022-06-30 | $0.15 |
| 2022-03-31 | $0.13 |
| 2021-12-31 | $0.13 |
| 2021-09-30 | $0.12 |
| 2021-06-30 | $0.17 |
| 2021-03-31 | $0.15 |
| 2020-12-31 | $0.64 |
| 2020-09-30 | $0.18 |
| 2020-06-30 | $-0.01 |
| 2020-03-31 | $0.16 |
| 2019-12-31 | $0.90 |
| 2019-09-30 | $0.09 |
| 2019-06-30 | $0.05 |
| 2019-03-31 | $0.12 |
| 2018-12-31 | $-0.04 |
| 2018-09-30 | $0.04 |
| 2018-06-30 | $0.02 |
| 2018-03-31 | $0.03 |
| 2017-12-31 | $-1.00 |
| 2017-09-30 | $-0.06 |
| 2017-06-30 | $-0.06 |
| 2017-03-31 | $-0.04 |
| 2016-12-31 | $-0.11 |
| 2016-09-30 | $-0.04 |
| 2016-06-30 | $0.11 |
| 2016-03-31 | $0.09 |
| 2015-12-31 | $-0.24 |
| 2015-09-30 | $0.05 |
| 2015-06-30 | $0.04 |
| 2015-03-31 | $-0.01 |
| 2014-12-31 | $-0.06 |
| 2014-09-30 | $0.09 |
| 2014-06-30 | $0.10 |
| 2014-03-31 | $0.13 |
| 2013-12-31 | $0.04 |
| 2013-09-30 | $0.06 |
| 2013-06-30 | $0.06 |
| 2013-03-31 | $0.01 |
| 2012-12-31 | $-0.21 |
| 2012-09-30 | $0.00 |
| 2012-06-30 | $0.13 |
| 2012-03-31 | $0.13 |
| 2011-12-31 | $0.00 |
| 2011-09-30 | $0.00 |
| 2011-06-30 | $0.00 |
| 2011-03-31 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.146B | $0.064B |
| FitLife Brands, Inc. provides nutritional and fitness enhancement products for health-conscious consumers. The Company's product includes Pump Fuel, ACG3, Core Fuel, Embrace Extreme, Lipo Rush, Cardio Cuts, Dr. Detox, Dr. Cholesterol and Dr. Joints. It market and sells product directly to athletic facilities, gyms and independent retailers. Fitlife Brands, Inc., formerly known as Bond Laboratories Inc., is headquartered in Omaha, Nebraska. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $189.676B | 21.18 |
| EssilorLuxottica (ESLOY) | France | $140.849B | 0.00 |
| Stryker (SYK) | United States | $138.598B | 26.59 |
| Medtronic (MDT) | Ireland | $131.983B | 18.29 |
| Boston Scientific (BSX) | United States | $115.097B | 25.46 |
| Medline (MDLN) | United States | $60.694B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $46.604B | 0.00 |
| ResMed (RMD) | United States | $38.903B | 25.98 |
| GE HealthCare Technologies (GEHC) | United States | $37.513B | 17.97 |
| Agilent Technologies (A) | United States | $36.753B | 23.23 |
| Koninklijke Philips (PHG) | Netherlands | $27.809B | 18.16 |
| Terumo (TRUMY) | Japan | $18.896B | 21.35 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.585B | 10.97 |
| Insulet (PODD) | United States | $17.105B | 53.09 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.943B | 0.00 |
| Baxter (BAX) | United States | $11.191B | 9.03 |
| Sunny Optical Technology (SNPTF) | China | $8.485B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.080B | 29.05 |
| Demant (WILYY) | Denmark | $6.521B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.301B | 13.10 |
| Envista Holdings (NVST) | United States | $4.063B | 20.59 |
| BillionToOne (BLLN) | United States | $3.897B | 0.00 |
| ICU Medical (ICUI) | United States | $3.694B | 23.45 |
| Prestige Consumer Healthcare (PBH) | United States | $3.152B | 14.63 |
| Haemonetics (HAE) | United States | $3.044B | 13.22 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.014B | 0.00 |
| Neogen (NEOG) | United States | $2.304B | 50.43 |
| Phibro Animal Health (PAHC) | United States | $2.027B | 17.86 |
| LeMaitre Vascular (LMAT) | United States | $1.973B | 39.72 |
| Perrigo (PRGO) | Ireland | $1.964B | 4.92 |
| QuidelOrtho (QDEL) | United States | $1.949B | 12.53 |
| AtriCure (ATRC) | United States | $1.800B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.466B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.466B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.421B | 20.57 |
| Green Thumb Industries (GTBIF) | United States | $1.417B | 62.09 |
| BioLife Solutions (BLFS) | United States | $1.060B | 314.57 |
| Capricor Therapeutics (CAPR) | United States | $1.053B | 0.00 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.937B | 10.59 |
| Tilray Brands (TLRY) | Canada | $0.821B | 0.00 |
| Valneva SE (VALN) | France | $0.803B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.790B | 0.00 |
| Omeros (OMER) | United States | $0.761B | 0.00 |
| CeriBell (CBLL) | United States | $0.717B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.578B | 15.66 |
| Verano Holdings (VRNO) | United States | $0.447B | 0.00 |
| Cerus (CERS) | United States | $0.411B | 0.00 |
| Brainsway (BWAY) | Israel | $0.410B | 69.77 |
| Canopy Growth (CGC) | Canada | $0.398B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.361B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.326B | 26.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Evolus (EOLS) | United States | $0.286B | 0.00 |
| Quanterix (QTRX) | United States | $0.275B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.234B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.219B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Utah Medical Products (UTMD) | United States | $0.201B | 18.06 |
| Organigram Global (OGI) | Canada | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.200B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.196B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.191B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.188B | 55.17 |
| Sanara MedTech (SMTI) | United States | $0.178B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.175B | 0.00 |
| Accendra Health (ACH) | United States | $0.170B | 1.71 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Apyx Medical (APYX) | United States | $0.151B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.129B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.69 |
| MacroGenics (MGNX) | United States | $0.108B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.104B | 0.00 |
| Biote (BTMD) | United States | $0.097B | 4.24 |
| Exagen (XGN) | United States | $0.076B | 0.00 |
| ImmuCell (ICCC) | United States | $0.055B | 23.49 |
| Sharps Technology (STSS) | United States | $0.041B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 29.85 |
| Cytosorbents (CTSO) | United States | $0.040B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.039B | 0.00 |
| Veru (VERU) | United States | $0.036B | 0.00 |
| Modular Medical (MODD) | United States | $0.034B | 0.00 |
| United-Guardian (UG) | United States | $0.033B | 16.63 |
| Jin Medical (ZJYL) | China | $0.022B | 0.00 |
| Bonk (BNKK) | United States | $0.019B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| INLIF (INLF) | China | $0.010B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| ZeroStack (ZSTK) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.005B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.002B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |